The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s preclinical CRO market report forecasts the preclinical CRO market size to grow to $7.26 Billion by 2027, with a CAGR (compound annual growth rate) of almost 9%.

Learn More On The Preclinical CRO Market Report 2023 – https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

Preclinical CRO Market Size Forecast
The global preclinical CRO market is expected to grow from $4.67 billion in 2022 to $5.15 billion in 2023 at a compound annual growth rate (CAGR) of 10.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global preclinical CRO market size is expected to reach $7.26 billion in 2027 at a CAGR of 8.9%.

North America held the largest preclinical CRO market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Preclinical CRO Market Driver ­– Increase In Demand For Preclinical Trials
According to the National Library of Medicine, a US-based medical library, 399,501 preclinical investigations were done by the end of 2021, and 437,536 preclinical trials were finished by the end of 2022 in April 2023. As a result, rising demand for preclinical studies is propelling the preclinical CRO market ahead.

Request for A Sample Of The Global Preclinical CRO Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp

Key Preclinical CRO Market Trend – Technological Advancement
To maintain their market position, major businesses in the preclinical CRO industry are implementing innovative technology. BenchSci, a Canada-based AI solutions firm for preclinical R&D, for example, announced ASCEND, an end-to-end SaaS (software as a service) platform and for preclinical drug discovery, in February 2023. This strategy tries to accelerate preclinical phase drug development pipelines by gaining biological insights into the fundamental underpinnings of disease. ASCEND uses BenchSci’s machine learning technology to retrieve experimental data from secure internal and public external sources. Using vetted ontology datasets, the platform compares experimental outcomes. As a result, the software may generate an evidence-based “map” of the biological mechanisms behind various diseases.

Preclinical CRO Market Segment
1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services
2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model
3) By Animal Model: Small Animal Model, Large Animal Model
4) By Model System: In Vivo, In Vitro
5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users

Preclinical CRO Market Major Players and Strategies
Major players in the preclinical CRO market are Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec, Medpace Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group Plc, Crown Bioscience International, Cynbiose, AmplifyBio, Vivotecnia, Simavita Ltd., BioEmission Technology Solutions, Altasciences, Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International, and Envigo.

Asahi Kasei Medical Co. Ltd., a Japanese chemical manufacturer, acquired Bionova Scientific, LLC for an unknown sum in June 2022. Asahi Kasei Medical will be able to expand its bioprocess business by adding a biopharmaceutical CDMO (contract development and manufacturing organisation) and reach a broader customer base, including those developing cutting-edge next-generation biopharmaceuticals, with the acquisition of Bionova Scientific. Bionova Scientific, LLC is a US-based company that provides contract process development and GMP-compliant contract manufacturing services to biopharmaceutical companies.

The Preclinical CRO Global Market Report 2023 covers regional data on preclinical CRO market size, preclinical CRO market trends and drivers, opportunities, strategies, and preclinical CRO market competitor analysis. The countries covered in the preclinical CRO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Preclinical CROs (contract research organisations) are research and development support organisations that provide the information required to guide a drug candidate through animal testing and into the clinical stage. Before entering clinical trials or being used for human care, a preclinical CRO assists new medical product companies in demonstrating product safety and efficacy in living animals that the Food and Drug Administration (FDA) judges to most closely mimic human anatomy.

View More Reports Related To The Preclinical CRO Market –
Crop Production Global Market Report 2023
Crop Protection Chemicals Global Market Report 2023
Crop Monitoring Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: